Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Netflix Inc.: The NFLX Stock Slump Is Bad Management, But It’s Fixable

NFLX execs have received plenty of hate for coming up short on subscriber growth, but it's too early to call the end for Netflix stock.

3 Retail Stocks Waving Red Flags Ahead of Earnings

Politicians and economists may cite the improving jobs market, but the inside data doesn't look positive for retail stocks ahead of earnings.

3 Troubled Pharma Stocks That Could Rally Soon

Pharma stocks have been hit hard by scandals, public outcries and industry-related setbacks, but there's still hope for a recovery.

3 Retirement Funds That Can Boost Your Portfolio

Before rushing in to reallocate your 401k portfolio, be sure to check out what these 3 mutual funds can do for your retirement!

2 International ETFs to Buy, 2 to Avoid

International ETFs can offer tremendous value, but knowing which ETFs to buy is especially critical in this uncertain environment.

3 Casino Stocks to Buy to Double Down on Casinos

Casinos have finally stopped the hemorrhaging but should you buy in on casino stocks now or wait for a better hand?

Recession Warning? 3 Restaurant Stocks That Are Rotting

Amid signs flashing recession risks in the past, the declining market value of restaurant stocks is one of the more alarming.

Microsoft Corporation: Is the MSFT Stock Party Over?

The MSFT stock price got a big boost from earnings season, but don't jump on the bandwagon on Microsoft stock before reading this.

Can These 3 Big Pharma Stocks Pull Off an Earnings Surprise?

Although there have been some grumblings towards Big Pharma stocks, look for the stronger names to produce the winnings.

Micron Technology, Inc.: Technical Reasons MU Stock Can Rally!

Although the bears may be circling Micron stock, there are a number of reasons why MU can prove the naysayers wrong!